Steven Sherman - Jun 21, 2022 Form 4 Insider Report for EKSO BIONICS HOLDINGS, INC. (EKSO)

Signature
/s/ Jerome Wong, as Attorney-in-Fact
Stock symbol
EKSO
Transactions as of
Jun 21, 2022
Transactions value $
-$9,259
Form type
4
Date filed
6/22/2022, 08:14 PM
Previous filing
May 26, 2022
Next filing
Jul 25, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction EKSO Common Stock Options Exercise $0 +15.6K +2.4% $0.00 664K Jun 21, 2022 Direct
transaction EKSO Common Stock Sale -$9.26K -5.33K -0.8% $1.74* 659K Jun 22, 2022 Direct F1, F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction EKSO Restricted Stock Units Options Exercise $0 -15.6K -12.5% $0.00 109K Jun 21, 2022 Common Stock 15.6K Direct F3, F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents shares sold by the Reporting Person on June 22, 2022 to cover tax withholding obligations incurred upon the vesting and settlement of the fifth installment of a restricted stock award originally reported by the Reporting Person in Form 4 filed with the Commission on March 10, 2022
F2 These shares were sold in a single transaction at a price of $1.7372 per share.
F3 The restricted stock units ("RSUs") were granted on March 8, 2022 in accordance with the terms of an Executive Employment Agreement entered into between the Reporting Person and the Company on January 21, 2022 (the "Effective Date").
F4 The RSUs vest in twelve equal installments on the first twelve monthly anniversaries of the Effective Date, starting February 21, 2022, such that the RSUs will be fully vested as of January 21, 2023. The fifth installment of RSUs vested on June 21, 2022 and were delivered to the Reporting Person upon settlement.